Using of keratin substrate for enrichment of HT29 colorectal cancer stem-like cells.


Journal

Journal of biomedical materials research. Part B, Applied biomaterials
ISSN: 1552-4981
Titre abrégé: J Biomed Mater Res B Appl Biomater
Pays: United States
ID NLM: 101234238

Informations de publication

Date de publication:
05 2019
Historique:
received: 20 03 2018
revised: 08 07 2018
accepted: 02 08 2018
pubmed: 4 10 2018
medline: 15 7 2020
entrez: 4 10 2018
Statut: ppublish

Résumé

Eradication of cancer stem-like cells (CSLCs) are becoming increasingly an important target for new cancer therapies. The ability to study their behavior in vitro will provide the opportunity for high-throughput testing of more effective treatments. In this study, spheroid-like structures' formation and enrichment of HT29 CSLCs were evaluated on a wool keratin-based substrate as a bio-mimic of natural extracellular matrix (ECM) proteins. The results indicated that culturing on keratin substrate increased spheroid formation ability and radio-/chemoresistance of HT29 cells. Moreover, cell surface expression of CD133 CSLCs' marker and the mRNA level of stemness genes such as Nanog, Oct4, and c-MYC were increased. These data suggest that keratin can potentially be used for spheroid-like structure formation and enrichment of HT29 CSLCs. In addition, it seems that the induction of stemness characteristics on keratin substrate is probably because of the activation of α

Identifiants

pubmed: 30281900
doi: 10.1002/jbm.b.34219
doi:

Substances chimiques

Biomarkers, Tumor 0
Keratins 68238-35-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1264-1271

Subventions

Organisme : Metabolic Disorders Research Center
Pays : International
Organisme : Golestan University of Medical Science
ID : 950616136
Pays : International

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Mahdi Abbasian (M)

Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Department of Biotechnology, College of Agriculture, Isfahan University of Technology, Isfahan, Iran.

Elham Mousavi (E)

Department of Medical Microbiology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Mohsen Khalili (M)

Medical Cellular and Molecular Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

Zahra Arab-Bafrani (Z)

Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Department of Biochemistry and Biophysics, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Health technology Research Center, Oxin Sabz Espadan Company, Esfahan university of Medical Sciences, Esfahan, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH